Supplemental food

Patent metadata

Field	Value
Publication number	US-9788560-B2
Application number	US-201514656736-A
Country	US
Kind code	B2
Filing date	Mar 13, 2015
Priority date	Mar 14, 2014
Publication date	Oct 17, 2017
Grant date	Oct 17, 2017

Abstract

Supplements for maintaining a healthy immune response include one or more extracts from rosemary, turmeric, green tea, ginger, holy basil, oregano, boswellia, black currant, and clove. The supplements may include an extract of thyme. The supplements may exclude anti-inflammatory drugs and certain anti-inflammatory herbs.

First claim

What is claimed is:

1. An oral dosage form for maintaining healthy immune response, the oral dosage form comprising about 100 mg supercritical extract of rosemary; about 50 mg hydroethanolic extract of rosemary; about 22 mg supercritical extract of turmeric; about 88 mg hydroethanolic extract of turmeric; about 100 mg extract of green tea; about 54 mg supercritical extract of ginger; about 46 mg hydroethanolic extract of ginger; about 42 mg hydroethanolic extract of holy basil; about 8 mg supercritical extract of holy basil; about 10 mg supercritical extract of oregano; about 10 mg hydroethanolic extract of oregano; about 7 mg supercritical extract of clove; about 10 mg supercritical extract of thyme; about 30 mg black currant; and a carrier.

2. The oral dosage form of claim 1 , wherein the supplement is substantially free of hu zhang extract.

3. The oral dosage form of claim 2 , further comprising boswellia serrata.

4. An oral dosage form for maintaining healthy immune response, the oral dosage form comprising about 100 mg supercritical extract of rosemary; about 50 mg hydroethanolic extract of rosemary; about 22 mg supercritical extract of turmeric; about 88 mg hydroethanolic extract of turmeric; about 100 mg extract of green tea; about 54 mg supercritical extract of ginger; about 46 mg hydroethanolic extract of ginger; about 42 mg hydroethanolic extract of holy basil; about 8 mg supercritical extract of holy basil; about 10 mg supercritical extract of oregano; about 10 mg hydroethanolic extract of oregano; about 7 mg supercritical extract of clove; about 5 mg to about 10 mg supercritical extract of thyme; about 30 to about 50 mg black currant; and a carrier.

5. An oral dosage form for maintaining healthy immune response, the oral dosage form comprising about 100 mg supercritical extract of rosemary; about 50 mg hydroethanolic extract of rosemary; about 25 mg supercritical extract of turmeric; about 100 mg hydroethanolic extract of turmeric; about 100 mg extract of green tea; about 15 mg supercritical extract of ginger; about 60 mg hydroethanolic extract of ginger; about 42 mg hydroethanolic extract of holy basil; about 8 mg supercritical extract of holy basil; about 10 mg supercritical extract of oregano; about 10 mg hydroethanolic extract of oregano; about 7 mg supercritical extract of clove; about 30 mg black currant; and a carrier.

6. The oral dosage form of claim 5 further comprising about 4 mg supercritical extract of chamomile and about 11 mg hydroethanolic extract of chamomile.

7. The oral dosage form of claim 5 further comprising about 150 mg boswellia serrata.

8. A method of moderating the inflammatory response to a transient pro-inflammatory stimulus, comprising administering the oral dosage form of claim 1 to a mammal prior to the mammal encountering the stimulus.

9. The method of claim 8 , wherein the transient pro-inflammatory stimulus is selected from the group consisting of exercise, an allergen, a transient increase in oxidative stress, and combinations thereof.

10. A method of moderating the inflammatory response to a transient pro-inflammatory stimulus, comprising administering the oral dosage form of claim 4 to a mammal prior to the mammal encountering the stimulus.

11. The method of claim 10 , wherein the transient pro-inflammatory stimulus is selected from the group consisting of exercise, an allergen, a transient increase in oxidative stress, and combinations thereof.

Assignees

• New Chapter Inc
• Procter & Gamble

Inventors

• Toomey Jennifer Marie
• Rigby Graham
• Schulick Paul

Classifications

• A61P37/02

  Immunomodulators · CPC title

• A61P37/00

  Drugs for immunological or allergic disorders · CPC title

• A61P37/08

  Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

• A61P39/00

  General protective or antinoxious agents · CPC title

• A61K36/324

  Boswellia, e.g. frankincense · CPC title